购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • GABA Receptor
    (2)
  • FKBP
    (1)
  • Others
    (5)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (2)
  • 35日内发货
    (1)
  • 1-2周
    (1)
  • 6-8周
    (2)
筛选
搜索结果
TargetMol产品目录中 "

anxiogenic

"的结果
  • 抑制剂&激动剂
    9
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    1
    TargetMol | Peptide_Products
  • Phenibut
    Phenybut, Fenigam, Fenibut, PhGABA, Aminophenylbutyric acid, 非尼布特, β-Phenyl-γ-aminobutyric acid
    T29901078-21-3
    Phenibut (Aminophenylbutyric acid) 是GABA-B 激动剂,可作为 GABA 类似物,主要作用于 GABAB 受体,具有抗焦虑和增强认知的作用。
    • ¥ 108
    现货
    规格
    数量
    TargetMol | Inhibitor Sale
  • Phenibut (hydrochloride)
    3-Amino-4-phenylbutyric acid hydrochloride, 3-氨基-4-苯基丁酸盐酸盐
    T86393060-41-1
    Phenibut hydrochloride (3-Amino-4-phenylbutyric acid hydrochloride) 是 GABA-B 激动剂,口服有活性,可作用于 GABAB 受体,充当 GABA 类似物。它具有促智 (增强认知) 及抗焦虑的能力。
    • ¥ 150
    现货
    规格
    数量
  • D-AP7
    T2712081338-23-0
    D-AP7 is a specific NMDA antagonist. D-AP7 enhances motility, exhibits anxiogenic-like effect and impairs consolidation in passive avoidance.
    • 待询
    规格
    数量
  • KT109
    KT-109,KT 109
    T277521402612-55-8
    KT109 is a selective inhibitor of DAGLβ (IC50 = 42 nM). KT109-treated wild-type mice displayed reductions in LPS-induced allodyni as well as in DAGL-β (- -) micea. Repeated KT109 administration prevented the expression of LPS-induced allodynia, without ev
    • ¥ 9120
    6-8周
    规格
    数量
  • LY 293284
    LY293284,LY-293284
    T27914141318-62-9
    LY 293284 is a potent, selective full agonist of 5-HT1A receptor with anxiogenic effects in animal studies.
    • ¥ 19400
    10-14周
    规格
    数量
  • Eltoprazine
    T3814598224-03-4
    Eltoprazine(DU28853) is a serenic or antiaggressive agent which as an agonist at the 5-HT1A and 5-HT1B receptors and as an antagonist at the 5-HT2C receptor.IC50 value:Target: 5-HT1A 1B agonist; 5-HT2C antagonistin vitro: The binding of [3H]eltoprazine to whole tissue sections was saturable and revealed an apparent dissociation constant (Kd) of 11 nM. Specific [3H]eltoprazine binding was completely displaced by 5-HT; conversely, unlabelled eltoprazine reduced [3H]5-HT binding to the levels of non-specific binding [1]. Eltoprazine evoked membrane changes that were similar to but much weaker than those induced by 5HT. Both the 5HT- and eltoprazine-evoked membrane hyperpolarizations were largely suppressed in the presence of spiperone [2].in vivo: eltoprazine is extremely effective in suppressing dyskinesia in experimental models, although this effect was accompanied by a partial worsening of the therapeutic effect of l-dopa. Interestingly, eltoprazine was found to (synergistically) potentiate the antidyskinetic effect of amantadine. The current data indicated that eltoprazine is highly effective in counteracting dyskinesia in preclinical models [3]. Rats were chronically treated with mianserin (10 mg kg i.p.) or eltoprazine (1 mg kg i.p.) and were tested in the elevated plus-maze test for anxiety. Mianserin and eltoprazine displayed opposite effects in the elevated plus-maze: mianserin induced anxiolytic-like effects, while eltoprazine showed anxiogenic-like ones [4]. [1]. Sijbesma H, et al. Eltoprazine, a drug which reduces aggressive behaviour, binds selectively to 5-HT1 receptor sites in the rat brain: an autoradiographic study. Eur J Pharmacol. 1990 Feb 20;177(1-2):55-66. [2]. Joels M, et al. Eltoprazine suppresses hyperpolarizing responses to serotonin in rat hippocampus. J Pharmacol Exp Ther. 1990 Apr;253(1):284-9. [3]. Bezard E, et al. Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia. Mov Disord. 2013 Jul;28(8):1088-96. [4]. Rocha B, et al. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels. Eur J Pharmacol. 1994 Sep 1;262(1-2):125-31.
    • ¥ 10600
    1-2周
    规格
    数量
  • BIBP 3226 trifluoroacetate
    T41188
    BIBP 3226 trifluoroacetate is a mixed non-peptide neuropeptide Y Y1(NPY Y1) and neuropeptide FF (NPFF) receptor antagonist (Kivalues are 1.1, 79, 108, > 1000, > 1000 and >1000 for rNPY Y1, hNPFF2, rNPFF, rNPY Y2, rNPY Y4and rNPY Y5respectively). Produces an anxiogenic-like effect in rats following i.c.v. administration.
    • 待估
    35日内发货
    规格
    数量
  • [DPro5] Corticotropin Releasing Factor, human, rat
    T76361195628-97-8
    [DPro5] Corticotropin Releasing Factor, human, rat 是人类和大鼠促肾上腺皮质激素释放因子 激素 R2 的选择性激动剂。作为一种下丘脑激素,促肾上腺皮质激素释放因子 (CRF) 能够促进肾上腺皮质激素 (ACTH) 和 β-内啡肽的分泌。值得注意的是,[DPro5] Corticotropin Releasing Factor, human, rat 并不触发典型的焦虑反应,而是能调控大鼠的学习与记忆过程。
    • 待询
    规格
    数量
  • FKBP51F67V-selective antagonist Ligand2
    T791841680228-76-5
    FKBP51F67V-selective antagonist Ligand2(示例3-3)是针对杏仁核中由FKBP51 F67V过表达引起的焦虑表型的有效逆转剂。本物质特异性地结合到FKBP51 F67V,与野生型FKBP51及FKBP52无亲和力。
    • ¥ 10600
    6-8周
    规格
    数量
没有更多数据了